Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
December-2022 Volume 24 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2022 Volume 24 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Nypa fruticans Wurmb inhibits melanogenesis in isobutylmethylxanthine‑treated melanoma via the PI3K/AKT/mTOR/CREB and MAPK signaling pathways

  • Authors:
    • So-Yeon Han
    • Tae-Won Jang
    • Hye-Jeong Park
    • Sung-Soo Oh
    • Jung-Bok Lee
    • Sung-Min Myoung
    • Jae-Ho Park
  • View Affiliations / Copyright

    Affiliations: Department of Medicinal Plant Science, Jungwon University, Goesan-gun, Chungcheongbuk-do 28024, Republic of Korea, Department of Pharmaceutical Science, Jungwon University, Goesan-gun, Chungcheongbuk-do 28024, Republic of Korea, Research Center, Kiposs Co., Ltd., Seoul 08584, Republic of Korea, Research and Innovation Center, Kyochon Food and Beverage Co., Ltd., Hwaseong-si, Gyeonggi-do 18469, Republic of Korea, Department of Public Health Administration, Jungwon University, Goesan-gun, Chungcheongbuk-do 28024, Republic of Korea
    Copyright: © Han et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 754
    |
    Published online on: November 8, 2022
       https://doi.org/10.3892/etm.2022.11691
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Malignant melanoma is responsible for 3.0 and 1.7% of cases of tumor incidence and tumor‑associated mortality, respectively, in the Caucasian population. Melanoma is a type of skin cancer that occurs when melanocytes mutate and divide uncontrollably. Nypa fruticans Wurmb (NF) is abundant in phytochemicals (polyphenols and flavonoids) and is traditionally used to treat diseases of the respiratory tract. The present study investigated the inhibitory effect of the ethyl acetate fraction of NF (ENF) on melanogenesis‑related factors in isobutylmethylxanthine‑treated B16F10 melanoma cells. Phenolics and flavonoids (caffeic acid, catechin, epicatechin and hirsutine) in ENF were analyzed via liquid chromatography‑mass spectrometry. In addition, the main factors involved in melanogenesis were identified using immunoblotting, reverse transcription‑polymerase chain reaction (RT‑PCR), RT‑quantitative PCR and immunofluorescence. ENF significantly suppressed the expression of tyrosinase (TYR) and TYR‑related proteins 1 and 2 (TYRP‑1/2), which are the main factors involved in melanogenesis. ENF also inhibited the expression of microphthalmia‑associated transcription factor (MITF) by phosphorylating the related cell signaling proteins (protein kinase B, mammalian target of rapamycin, phosphoinositide 3‑kinase and cAMP response element‑binding protein). Furthermore, ENF inhibited the phosphorylation of extracellular signal‑regulated kinase and thereby downregulated melanogenesis. In conclusion, ENF inhibited melanogenesis by suppressing MITF, which controls TYRP‑1/2 and TYR. These results suggested that ENF may be a natural resource that can inhibit excessive melanin expression by regulating various melanogenesis pathways.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Gilchrest BA and Eller MS: DNA photodamage stimulates melanogenesis and other photoprotective responses. J Investig Dermatol Symp Proc. 4:35–40. 1999.PubMed/NCBI View Article : Google Scholar

2 

Swalwell H, Latimer J, Haywood RM and Birch-Machin MA: Investigating the role of melanin in UVA/UVB-and hydrogen peroxide-induced cellular and mitochondrial ROS production and mitochondrial DNA damage in human melanoma cells. Free Radic Biol Med. 52:626–634. 2012.PubMed/NCBI View Article : Google Scholar

3 

Buscà R and Ballotti R: Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Melanoma Res. 13:60–69. 2000.PubMed/NCBI View Article : Google Scholar

4 

Jiang Z, Xu J, Long M, Tu Z, Yang G and He G: 2,3,5,4'-Tetrahyd-roxystilbene-2-O-β-d-glucoside (THSG) induces melanogenesis in B16 cells by MAP kinase activation and tyrosinase upregulation. Life Sci. 85:345–350. 2009.PubMed/NCBI View Article : Google Scholar

5 

Ye Y, Chu JH, Wang H, Xu H, Chou GX, Leung AK, Fong WF and Yu ZL: Involvement of p38 MAPK signaling pathway in the anti-melanogenic effect of San-bai-tang, a Chinese herbal formula, in B16 cells. J Ethnopharmacol. 132:533–535. 2010.PubMed/NCBI View Article : Google Scholar

6 

Jung E, Lee J, Huh S, Lee J, Kim YS, Kim G and Park D: Phloridzin-induced melanogenesis is mediated by the cAMP signaling pathway. Food Chem Toxicol. 47:2436–2440. 2009.PubMed/NCBI View Article : Google Scholar

7 

Han HJ, Park SK, Kang JY, Kim JM, Yoo SK and Heo HJ: Anti-melanogenic effect of ethanolic extract of Sorghum bicolor on IBMX-induced melanogenesis in B16/F10 melanoma cells. Nutrients. 12(832)2020.PubMed/NCBI View Article : Google Scholar

8 

Bertolotto C, Abbe P, Hemesath TJ, Bille K, Fisher DE, Ortonne JP and Bauotti R: Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol. 142:827–835. 1998.PubMed/NCBI View Article : Google Scholar

9 

Park WS, Kwon O, Yoon TJ and Chung JH: Anti-graying effect of the extract of Pueraria thunbergiana via upregulation of cAMP/MITF-M signaling pathway. J Dermatol Sci. 75:153–155. 2014.PubMed/NCBI View Article : Google Scholar

10 

Kang YG, Choi EJ, Choi Y and Hwang JK: 5,7-Dimethoxyflavone induces melanogenesis in B16F10 melanoma cells through cAMP-dependent signalling. Exp Dermatol. 20:445–447. 2011.PubMed/NCBI View Article : Google Scholar

11 

Jang JY, Lee JH, Kang BW, Chung KT, Choi YH and Choi BT: Dichloromethane fraction of Cimicifuga heracleifolia decreases the level of melanin synthesis by activating the ERK or AKT signaling pathway in B16F10 cells. Exp Dermatol. 18:232–237. 2009.PubMed/NCBI View Article : Google Scholar

12 

Jang JY, Kim HN, Kim YR, Choi WY, Choi YH, Shin HK and Choi BT: Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells. J Ethnopharmacol. 137:1207–1214. 2011.PubMed/NCBI View Article : Google Scholar

13 

Kim DS, Jeong YM, Park IK, Hahn HG, Lee HK, Kwon SB, Jeong JH, Yang SJ, Sohn UD and Park KC: A new 2-imino-1,3-thiazoline derivative, KHG22394, inhibits melanin synthesis in mouse B16 melanoma cells. Biol Pharm Bull. 30:180–183. 2007.PubMed/NCBI View Article : Google Scholar

14 

Cho JH, Robinson JP, Arave RA, Burnett WJ, Kircher DA, Chen G, Davies MA, Grossmann AH, VanBrocklin MW, McMahon M and Holmen SL: AKT1 activation promotes development of melanoma metastases. Cell Rep. 13:898–905. 2015.PubMed/NCBI View Article : Google Scholar

15 

Mantiquilla JA, Shiao MS, Lu HY, Sridith K, Sidique SN, Liyanage WK, Chu YL, Shih HC and Chiang YC: Deep structured populations of geographically isolated nipa (Nypa fruticans Wurmb.) in the Indo-West Pacific revealed using microsatellite markers. Frontiers in Plant Science 13, 2022.

16 

Prasad N, Yang B, Kong KW, Sun J, Azlan A, Ismail A and Romi ZB: Phytochemicals and antioxidant capacity from Nypa fruticans Wurmb. fruit. Evid Based Complementary Altern Med: Article ID 154606, 9 pages: 2013.

17 

Kim D, Park J, Kim J, Han C, Yoon J, Kim N, Seo J and Lee C: Flavonoids as mushroom tyrosinase inhibitors: A fluorescence quenching study. J Agric Food Chem. 54:935–941. 2006.PubMed/NCBI View Article : Google Scholar

18 

Kubo I and Kinst-Hori I: Flavonols from saffron flower: Tyrosinase inhibitory activity and inhibition mechanism. J Agric Food Chem. 47:4121–4125. 1999.PubMed/NCBI View Article : Google Scholar

19 

Itoh K, Hirata N, Masuda M, Naruto S, Murata K, Wakabayashi K and Matsuda H: Inhibitory effects of Citrus hassaku extract and its flavanone glycosides on melanogenesis. Biol Pharm Bull. 32:410–415. 2009.PubMed/NCBI View Article : Google Scholar

20 

Rodboon T, Okada S and Suwannalert P: Germinated riceberry rice enhanced protocatechuic acid and vanillic acid to suppress melanogenesis through cellular oxidant-related tyrosinase activity in B16 cells. Antioxidants. 9(247)2020.PubMed/NCBI View Article : Google Scholar

21 

Kang MS, Lee GH, Choi GE, Yoon HG and Hyun KY: Neuroprotective effect of Nypa fruticans wurmb by suppressing TRPV1 following sciatic nerve crush injury in a rat. Nutrients. 12(2618)2020.PubMed/NCBI View Article : Google Scholar

22 

Kang MS and Hyun KY: Antinociceptive and anti-inflammatory effects of Nypa fruticans wurmb by suppressing TRPV1 in the sciatic neuropathies. Nutrients. 12(135)2020.PubMed/NCBI View Article : Google Scholar

23 

Jang TW and Park JH: Anti-inflammatory effects of Abeliophyllum distichum nakai (Cultivar Okhwang 1) callus through inhibition of PI3K/Akt, NF-κB and MAPK signaling pathways in lipopolysaccharide-induced macrophages. Processes. 9(1071)2021.

24 

Son KH, Baek JK, Park SB, Kin HN, Park GH, Son HJ, Eo HJ, Song JH, Jeong HJ and Jeong JB: Enhancement of melanin synthesis by the branch extracts of Vaccinium oldhamii through activating tyrosinase activity in B16F10 melanoma cells. Korean J Plant Res. 31:547–553. 2018.

25 

Jin KS, Oh YN, Hyun SK, Kwon HJ and Kim BW: Betulinic acid isolated from Vitis amurensis root inhibits 3-isobutyl-1-methylxanthine induced melanogenesis via the regulation of MEK/ERK and PI3K/Akt pathways in B16F10 cells. Food Chem Toxicol. 68:38–43. 2014.PubMed/NCBI View Article : Google Scholar

26 

Xie X, White EP and Mehnert JM: Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma. PLoS One. 8(e55096)2013.PubMed/NCBI View Article : Google Scholar

27 

Werzowa J, Koehrer S, Strommer S, Cejka D, Fuereder T, Zebedin E and Wacheck V: Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma in vitro and in vivo. J Invest Dermatol. 131:495–503. 2011.PubMed/NCBI View Article : Google Scholar

28 

Karbowniczek M, Spittle CS, Morrison T, Wu H and Henske EP: mTOR is activated in the majority of malignant melanomas. J Invest Dermatol. 128:980–987. 2008.PubMed/NCBI View Article : Google Scholar

29 

Meier F, Schittek B, Busch S, Garbe C, Smalley K, Stayamoorthy K, Li G and Herdyn M: The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma. Front Biosci. 10:2986–3001. 2005.PubMed/NCBI View Article : Google Scholar

30 

Costin GE and Hearing VJ: Human skin pigmentation: Melanocytes modulate skin color in response to stress. FASEB J. 21:976–994. 2007.PubMed/NCBI View Article : Google Scholar

31 

D'Mello SA, Finlay GJ, Baguley BC and Askarian-Amiri ME: Signaling pathways in melanogenesis. Int J Mol Sci. 17(1144)2016.PubMed/NCBI View Article : Google Scholar

32 

Boissy RE, Visscher M and DeLong MA: DeoxyArbutin: A novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Exp Dermatol. 14:601–608. 2005.PubMed/NCBI View Article : Google Scholar

33 

Bloom van Staden A, Oosthuizen CB and Lall N: The effect of Aspalathus linearis (Burm. f.) R. Dahlgren and its compounds on tyrosinase and melanogenesis. Sci Rep. 11(7020)2021.PubMed/NCBI View Article : Google Scholar

34 

Zhang X, Li J, Li Y, Liu Z, Lin Y and Huang JA: Anti-melanogenic effects of epigallocatechin-3-gallate (EGCG), epicatechin-3-gallate (ECG) and gallocatechin-3-gallate (GCG) via down-regulation of cAMP/CREB/MITF signaling pathway in B16F10 melanoma cells. Fitoterapia. 145(104634)2020.PubMed/NCBI View Article : Google Scholar

35 

Ramli S and Ruangrungsi N: Tyrosinase inhibition, antioxidant activity and total phenolic content of selected mimosaceae pericarps ethanolic extracts. Int J Pharm. 4:47–57. 2021.

36 

Sato K and Toriyama M: Depigmenting effect of catechins. Molecules. 14:4425–4432. 2009.PubMed/NCBI View Article : Google Scholar

37 

Chen Z, Liang J, Zhang C and Rodrigues CJ Jr: Epicatechin and catechin may prevent coffee berry disease by inhibition of appressorial melanization of Colletotrichum kahawae. Biotechnol Lett. 28:1637–1640. 2006.PubMed/NCBI View Article : Google Scholar

38 

Ohguchi K, Nakajima C, Oyama M, Iinuma M, Itoh T, Akao Y, Nozawa Y and Ito M: Inhibitory effects of flavonoid glycosides isolated from the peel of Japanese persimmon (Diospyros kaki ‘Fuyu’) on melanin biosynthesis. Biol Pharm Bull. 33:122–124. 2010.PubMed/NCBI View Article : Google Scholar

39 

Balogun TA, Ipinloju N, Abdullateef OT, Moses SI, Omoboyowa DA, James AC, Saibu OA, Akinyemi WF and Oni EA: Computational evaluation of bioactive compounds from Colocasia affinis schott as a novel EGFR inhibitor for cancer treatment. Cancer Inform. 20(11769351211049244)2021.PubMed/NCBI View Article : Google Scholar

40 

Wang W, Mao S, Yu H, Wu H, Shan X, Zhang X, Cui G and Liu X: Pinellia pedatisecta lectin exerts a proinflammatory activity correlated with ROS-MAPKs/NF-κB pathways and the NLRP3 inflammasome in RAW264.7 cells accompanied by cell pyroptosis. Int Immunopharmacol. 66:1–12. 2019.PubMed/NCBI View Article : Google Scholar

41 

An JH, Won HJ, Seo SK, Kim DY, Ku CS, Oh SK and Ryu HW: Utilization of [6]-gingerol as an origin discriminant marker influencing melanin inhibitory activity relative to its content in Pinellia ternata. J Appl Biol Chem. 59:323–330. 2016.

42 

Byun EB, Song HY, Mushtaq S, Kim HM, Kang JA, Yang MS, Sung NY, Jang BS and Byung EH: Gamma-irradiated luteolin inhibits 3-isobutyl-1-methylxanthine-induced melanogenesis through the regulation of CREB/MITF, PI3K/Akt and ERK pathways in B16BL6 melanoma cells. J Med Food. 20:812–819. 2017.PubMed/NCBI View Article : Google Scholar

43 

Hsiao JJ and Fisher DE: The roles of microphthalmia-associated transcription factor and pigmentation in melanoma. Arch Biochem Biophys. 563:28–34. 2014.PubMed/NCBI View Article : Google Scholar

44 

Du J, Widlund HR, Horstmann MA, Ramaswamy S, Ross K, Huber WE, Nishimura EK, Golub TR and Fisher DE: Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell Int. 6:565–576. 2004.PubMed/NCBI View Article : Google Scholar

45 

Buscà R, Berra E, Gaggioli C, Khaled M, Bille K, Marchetti B, Thyss R, Fitsialos G, Larribère L, Bertolotto C, et al: Hypoxia-inducible factor 1α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. J Cell Biol. 170:49–59. 2005.PubMed/NCBI View Article : Google Scholar

46 

McGill GG, Haq R, Nishimura EK and Fisher DE: c-Met expression is regulated by Mitf in the melanocyte lineage. J Biol Chem. 281:10365–10373. 2006.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Han S, Jang T, Park H, Oh S, Lee J, Myoung S and Park J: <em>Nypa fruticans</em> Wurmb inhibits melanogenesis in isobutylmethylxanthine‑treated melanoma via the PI3K/AKT/mTOR/CREB and MAPK signaling pathways. Exp Ther Med 24: 754, 2022.
APA
Han, S., Jang, T., Park, H., Oh, S., Lee, J., Myoung, S., & Park, J. (2022). <em>Nypa fruticans</em> Wurmb inhibits melanogenesis in isobutylmethylxanthine‑treated melanoma via the PI3K/AKT/mTOR/CREB and MAPK signaling pathways. Experimental and Therapeutic Medicine, 24, 754. https://doi.org/10.3892/etm.2022.11691
MLA
Han, S., Jang, T., Park, H., Oh, S., Lee, J., Myoung, S., Park, J."<em>Nypa fruticans</em> Wurmb inhibits melanogenesis in isobutylmethylxanthine‑treated melanoma via the PI3K/AKT/mTOR/CREB and MAPK signaling pathways". Experimental and Therapeutic Medicine 24.6 (2022): 754.
Chicago
Han, S., Jang, T., Park, H., Oh, S., Lee, J., Myoung, S., Park, J."<em>Nypa fruticans</em> Wurmb inhibits melanogenesis in isobutylmethylxanthine‑treated melanoma via the PI3K/AKT/mTOR/CREB and MAPK signaling pathways". Experimental and Therapeutic Medicine 24, no. 6 (2022): 754. https://doi.org/10.3892/etm.2022.11691
Copy and paste a formatted citation
x
Spandidos Publications style
Han S, Jang T, Park H, Oh S, Lee J, Myoung S and Park J: <em>Nypa fruticans</em> Wurmb inhibits melanogenesis in isobutylmethylxanthine‑treated melanoma via the PI3K/AKT/mTOR/CREB and MAPK signaling pathways. Exp Ther Med 24: 754, 2022.
APA
Han, S., Jang, T., Park, H., Oh, S., Lee, J., Myoung, S., & Park, J. (2022). <em>Nypa fruticans</em> Wurmb inhibits melanogenesis in isobutylmethylxanthine‑treated melanoma via the PI3K/AKT/mTOR/CREB and MAPK signaling pathways. Experimental and Therapeutic Medicine, 24, 754. https://doi.org/10.3892/etm.2022.11691
MLA
Han, S., Jang, T., Park, H., Oh, S., Lee, J., Myoung, S., Park, J."<em>Nypa fruticans</em> Wurmb inhibits melanogenesis in isobutylmethylxanthine‑treated melanoma via the PI3K/AKT/mTOR/CREB and MAPK signaling pathways". Experimental and Therapeutic Medicine 24.6 (2022): 754.
Chicago
Han, S., Jang, T., Park, H., Oh, S., Lee, J., Myoung, S., Park, J."<em>Nypa fruticans</em> Wurmb inhibits melanogenesis in isobutylmethylxanthine‑treated melanoma via the PI3K/AKT/mTOR/CREB and MAPK signaling pathways". Experimental and Therapeutic Medicine 24, no. 6 (2022): 754. https://doi.org/10.3892/etm.2022.11691
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team